Literature DB >> 32086053

Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization.

Romeo Romagnoli1, Filippo Prencipe2, Paola Oliva2, Maria Kimatrai Salvador2, Andrea Brancale3, Salvatore Ferla3, Ernest Hamel4, Giampietro Viola5, Roberta Bortolozzi6, Leentje Persoons7, Jan Balzarini7, Sandra Liekens7, Dominique Schols7.   

Abstract

A new class of inhibitors of tubulin polymerization based on the 2-alkoxycarbonyl-3-(3',4',5'-trimethoxyanilino)indole molecular skeleton was synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization and cell cycle effects. The results presented show that the methoxy substitution and location on the indole nucleus plays an important role in inhibition of cell growth, and the most favorable position for the substituent was at C-6. In addition, a small-size ester function (methoxy/ethoxycarbonyl) at the 2-position of the indole core was desirable. Also, analogues that were alkylated with methyl, ethyl or n-propyl groups or had a benzyl moiety on the N-1 indolic nitrogen retained activity equivalent to those observed in the parent N-1H analogues. The most promising compounds of the series were 2-methoxycarbonyl-3-(3',4'.5'-trimethoxyanilino)-5-methoxyindole 3f and 1-methyl-2-methoxycarbonyl-3-(3',4'.5'-trimethoxyanilino)-6-methoxy-indole 3w, both of which target tubulin at the colchicine site with antitubulin activities comparable to that of the reference compound combretastatin A-4.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiproliferative activity; Indole; Microtubules; Structure-activity relationship; Tubulin

Mesh:

Substances:

Year:  2020        PMID: 32086053     DOI: 10.1016/j.bioorg.2020.103665

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  6 in total

1.  Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents.

Authors:  Paola Oliva; Romeo Romagnoli; Barbara Cacciari; Stefano Manfredini; Chiara Padroni; Andrea Brancale; Salvatore Ferla; Ernest Hamel; Diana Corallo; Sanja Aveic; Noemi Milan; Elena Mariotto; Giampietro Viola; Roberta Bortolozzi
Journal:  Pharmaceutics       Date:  2022-06-02       Impact factor: 6.525

Review 2.  Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).

Authors:  Ashima Dhiman; Rupam Sharma; Rajesh K Singh
Journal:  Acta Pharm Sin B       Date:  2022-04-01       Impact factor: 14.903

3.  Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3',4',5'-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold.

Authors:  Romeo Romagnoli; Filippo Prencipe; Paola Oliva; Barbara Cacciari; Jan Balzarini; Sandra Liekens; Ernest Hamel; Andrea Brancale; Salvatore Ferla; Stefano Manfredini; Matteo Zurlo; Alessia Finotti; Roberto Gambari
Journal:  Molecules       Date:  2020-04-07       Impact factor: 4.411

4.  Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.

Authors:  Edgar López-López; Carlos M Cerda-García-Rojas; José L Medina-Franco
Journal:  Molecules       Date:  2021-04-24       Impact factor: 4.411

Review 5.  Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations.

Authors:  Sheng Tang; Zhihui Zhou; Zhiyan Jiang; Wufu Zhu; Dan Qiao
Journal:  Molecules       Date:  2022-02-28       Impact factor: 4.411

6.  New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3H)-benzothiazolones.

Authors:  Gjorgji Atanasov; Rusi I Rusew; Vladimir M Gelev; Christo D Chanev; Rosica Nikolova; Boris L Shivachev; Ognyan I Petrov; Margarita D Apostolova
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.